top of page
Clinical Research
Along with normal clinical service, wide range of clinical trials also provided in our center
We are actively recruiting patient to participate in the following clinical trials
Please send referral letter to medicaloncology@hku.hk if interested
Genitourinary
Protocol Number
Protocol Title
Experimental agent
Principle Investigator
XL092-304
A Phase 3 Randomized Open-Label study of XL092 + Nivolumab vs Sunitinib
XL092 + Nivolumab
VS
Sunitinib
A Phase 3, Open Label, Randomised, 3-Arm, Multi-Centre Study of Savolitinib plus Durvalumab versus Sunitinib and Durvalumab Monotheraphy in Participants with MET-Driven, Unresectable and Locally Advanced or Metastatic Papillary Renal Cell Carcinoma (PRCC) (SAMETA)
durvalumab and savolitinib
vs
durvalumab
vs
sunitinib
bottom of page